Insights

Innovative Therapeutics Focus OncoGenex specializes in developing first-in-class cancer treatments targeting treatment resistance, indicating potential demand for advanced biotech solutions and research collaborations.

Mid-Size Market Presence With an estimated revenue range of 1 to 10 million dollars and a small team, the company is in an early growth stage, making it receptive to partnerships that can support scaling and product development.

Technology Utilization Using cloud services like Google Cloud and Nginx suggests an openness to digital infrastructure enhancements, providing opportunities to offer cloud-based research tools or IT solutions.

Funding Natality Though specific funding data is absent, the company's focus on innovative therapeutics and industry positioning suggests potential for grants, venture capital, or strategic investments.

Market Opportunities As a leader in a niche segment of cancer therapeutics, OncoGenex offers opportunities for joint research, licensing agreements, or supply partnerships with larger biotech and pharmaceutical companies.

Similar companies to OncoGenex Pharmaceuticals

OncoGenex Pharmaceuticals Tech Stack

OncoGenex Pharmaceuticals uses 2 technology products and services including Google Cloud, Nginx, and more. Explore OncoGenex Pharmaceuticals's tech stack below.

Google Cloud
Infrastructure As A Service
Nginx
Web Servers

Media & News

OncoGenex Pharmaceuticals's Email Address Formats

OncoGenex Pharmaceuticals uses at least 1 format(s):

OncoGenex Pharmaceuticals Email Formats	Example	Percentage
FLast@oncogenex.com	JDoe@oncogenex.com	50%
FLast@oncogenex.com	JDoe@oncogenex.com	50%

Frequently Asked Questions

Where is OncoGenex Pharmaceuticals's headquarters located?

OncoGenex Pharmaceuticals's main headquarters is located at 1522 217th Place SE Bothell, Washington 98021 United States. The company has employees across 1 continents, including North America.

What is OncoGenex Pharmaceuticals's phone number?

You can contact OncoGenex Pharmaceuticals's main corporate office by phone at

+1-425-686-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is OncoGenex Pharmaceuticals's official website and social media links?

OncoGenex Pharmaceuticals's official website is oncogenex.com and has social profiles on LinkedIn.

How much revenue does OncoGenex Pharmaceuticals generate?

As of July 2025, OncoGenex Pharmaceuticals's annual revenue is estimated to be $26M.

What is OncoGenex Pharmaceuticals's SIC code NAICS code?

OncoGenex Pharmaceuticals's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does OncoGenex Pharmaceuticals have currently?

As of July 2025, OncoGenex Pharmaceuticals has approximately 11 employees across 1 continents, including North America. Key team members include Vice President Marketing & Corporate Communications: J. W.Director , Information Technology: K. N.Senior Paralegal: S. T.. Explore OncoGenex Pharmaceuticals's employee directory with LeadIQ.

What industry does OncoGenex Pharmaceuticals belong to?

OncoGenex Pharmaceuticals operates in the Biotechnology Research industry.

What technology does OncoGenex Pharmaceuticals use?

OncoGenex Pharmaceuticals's tech stack includes Google CloudNginx.

What is OncoGenex Pharmaceuticals's email format?

OncoGenex Pharmaceuticals's email format typically follows the pattern of FLast@oncogenex.com. Find more OncoGenex Pharmaceuticals email formats with LeadIQ.

OncoGenex Pharmaceuticals

Q: How many employees does OncoGenex Pharmaceuticals have currently?

OncoGenex Pharmaceuticals has approximately 11 employees.

Q: What technology does OncoGenex Pharmaceuticals use?

OncoGenex Pharmaceuticals's tech stack includes Nginx, Google Cloud.

Biotechnology ResearchWashington, United States11-50 Employees

OncoGenex is a leader in the development of novel therapeutics that target important mechanisms of treatment resistance in cancer. We are committed to the development and commercialization of first-in-class, innovative therapies that have the potential to redefine treatment outcomes for patients with a variety of cancers.

Company Overview

Headquarters: 1522 217th Place SE Bothell, Washington 98021 United States
Phone number: +1-425-686-****
Website: oncogenex.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 11-50